(S)-1-BOC-3-METHANESULFONYLOXYPYRROLIDINE, 95.0%, 10g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), 99%, 10mg

N-Hydroxy-4-nitrobenzimidoyl chloride, 95%, 250mg

4-Cyclopentylmorpholine, 95.0%, 100g

2-(5-Amino-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4(3H)-one, 95.0%, 250mg

4-Boc-Aminonicotinic acid, 95.0%, 250mg

(S)-2-Amino-4-bromopent-4-enoic acid, 95.0%, 100mg

o-(4-Biphenylylcarbonyl)benzoic acid, 95.0%, 5g

N4-Hydroxycytidine>95.0%(HPLC)100mg

2-Chloro-N-cyclopropyl-4-fluoro-3-methoxybenzamide, 98%, 1g

2-(2-(Trifluoromethyl)phenoxy)tetrahydro-2H-pyran, 98%, 1g

2-BROMOPROPIONIC ACID, = 99% (GC), 1kg

6-Bromo-4-methylpyridin-3-amine, 97.0%, 10g